A second opinion can help you understand the diagnosis, stage, treatment options and the role of surgery in testicular cancer. It may be especially useful when the pathology report is complex, scans show enlarged retroperitoneal lymph nodes, chemotherapy has been advised, a residual mass remains after treatment, or RPLND is being considered.
A second opinion does not mean you must change your treating doctor. It is an opportunity to review the available information, clarify the reasoning behind the proposed plan, and understand whether other evidence-based options may be appropriate.
Testicular cancer can progress quickly in some situations. If treatment is urgent—particularly when there is extensive metastatic disease—do not delay starting recommended care while arranging another consultation. Ask your treating team how much time is safe for review.
When ultrasound suggests a suspicious intratesticular tumour, prompt specialist evaluation is important. For suspected testicular germ-cell cancer, the usual surgical approach is radical inguinal orchidectomy rather than a biopsy through the scrotum. The exact plan depends on the presentation, imaging and clinical circumstances.
Before surgery, the clinician generally reviews the ultrasound, examines both testes and relevant lymph-node areas, and measures AFP, beta-hCG and LDH. Staging scans and other investigations are arranged as appropriate. If there is a life-threatening situation due to extensive metastatic disease, the sequence of treatment may differ and should be decided urgently by the specialist team.
A second opinion can help clarify the diagnosis, the planned surgical approach, whether a testicular prosthesis should be discussed, and how to address fertility and testosterone-related questions before treatment.
After orchidectomy, treatment decisions depend on the pathology report, tumour-marker trends and staging scans. Some patients with Stage I disease may be offered active surveillance, while others may be advised adjuvant treatment or additional surgery based on their specific risk and tumour type.
No single treatment plan applies to every patient. A useful second opinion should explain the expected benefit, risks, possible need for additional treatment and follow-up requirements for each reasonable option.
RPLND (retroperitoneal lymph node dissection) removes selected lymph-node tissue from the back of the abdomen. It may be considered in selected patients with non-seminoma and in specific other situations after specialist review. The operation can be technically demanding because lymph nodes may lie close to the aorta, inferior vena cava, renal vessels, ureters and bowel.
If RPLND has been recommended, questions for a second opinion may include:
The robotic approach is not automatically better for every patient. The appropriate approach depends on the disease extent, prior chemotherapy or surgery, anatomy, the need for complete removal and the surgical team’s experience.
A CT scan may continue to show a residual retroperitoneal mass after chemotherapy. In non-seminoma, the mass may contain teratoma, viable germ-cell cancer, fibrosis or necrosis. Normal tumour markers do not exclude residual teratoma.
The decision about surgery depends on the original histology, residual mass size and location, tumour-marker trends, chemotherapy response and fitness for surgery. Seminoma residual masses are assessed differently, and RPLND is not routinely required for every residual seminoma mass. In selected situations, further imaging, including FDG-PET/CT for an appropriately sized seminoma residual mass at the recommended interval, may help guide management.
For a second opinion, bring both the pre-chemotherapy and post-chemotherapy CT images, not just the written reports. Comparing the images helps assess the response and the relationship of the mass to major blood vessels and nearby organs.
If testicular cancer returns or has spread to distant sites, management should be coordinated with a team experienced in germ-cell tumours. Treatment may involve cisplatin-based chemotherapy, surgery for selected residual or recurrent disease, radiotherapy in selected seminoma situations, or specialised salvage treatment. The right option depends on histology, tumour markers, sites of disease, previous treatment and response.
Late relapse—recurrence after a long interval—requires particular attention to the original pathology, current imaging and tumour-marker results. In selected late-relapsing non-seminoma cases, complete surgical removal of resectable disease can be an important part of treatment planning.
A second opinion can help review whether the diagnosis and risk group are correct, whether the proposed treatment is consistent with current guidance, and whether specialist multidisciplinary input is needed. It should not replace urgent treatment when the treating team considers treatment time-critical.
Testicular cancer often affects people who may wish to have children in the future. Sperm banking should be discussed before chemotherapy or other treatment whenever feasible. Do not delay urgent cancer treatment without guidance from the treating team.
If orchidectomy is planned, a testicular prosthesis can be discussed before surgery. It is an implant intended to restore the appearance of the scrotum; it does not produce testosterone or restore fertility. Timing, suitability, possible complications and expectations should be discussed with the surgeon.
After treatment, follow-up may include tumour markers, imaging and clinical review based on the stage and treatment received. Survivorship care may also address testosterone deficiency, fertility, sexual health, cardiovascular risk factors, hearing or nerve symptoms after chemotherapy, emotional wellbeing and return to normal activities. Follow the individual schedule provided by your treating team.
It should not delay urgent treatment. Ask your treating doctor how quickly a review is needed and whether reports can be reviewed in parallel with treatment planning.
No. A second opinion can simply help you understand the diagnosis and options. You may continue with your current treating team.
Reports and imaging may help with an initial review, but an in-person examination or additional investigations may be needed before a final recommendation. Confirm what records are required when booking.
It can help assess the indication, but the decision depends on complete clinical details, imaging, tumour markers, pathology and sometimes multidisciplinary review.
No. Marker results must be interpreted with histology and imaging. Some residual disease, including teratoma, may not produce elevated markers.
No. Suitability depends on the disease, mass size and location, previous treatment, required dissection and the surgeon’s experience.
It can be useful because management differs by tumour type and may involve complex surgery. Bring the original and post-treatment scans and full treatment records.
| Item | What is reviewed | Why it matters |
|---|---|---|
| Histopathology | Tumour type, lymphovascular invasion, rete testis invasion, tumour size | Defines risk group and adjuvant options |
| Tumour markers | AFP, beta-hCG and LDH before and after orchidectomy | Shows disease burden and response |
| Imaging | Scrotal ultrasound and CT of chest, abdomen and pelvis | Sets the clinical stage |
| Prior treatment | Chemotherapy cycles and response, residual mass size | Decides whether RPLND has a role |
A testicular cancer second opinion reviews the original histopathology (seminoma or non-seminomatous germ cell tumour), AFP, beta-hCG and LDH trends, scrotal ultrasound and CT chest, abdomen and pelvis. It then clarifies the stage and whether surgery, surveillance or chemotherapy fits.
No. A second opinion should not delay urgent care. Radical inguinal orchidectomy is usually done promptly when a germ-cell tumour is suspected, and sperm banking can be arranged first. The review is fitted around these steps.
It is most useful when the stage is unclear, markers stay raised after orchidectomy, a residual retroperitoneal mass persists after chemotherapy, or RPLND is being considered.
Selected videos and anonymised case summaries from Dr Swati Shah’s testicular cancer practice, shared for patient education. Every patient’s plan is individual, and a past case does not predict an individual result.
When a testicular tumour is suspected, the surgical approach is extremely important. A scrotal incision should generally be avoided because it can disrupt the normal lymphatic drainage pathways of the testis and potentially increase the risk of local tumour contamination and altered patterns of spread.
The standard oncological procedure for a suspected testicular malignancy is high inguinal orchidectomy. Through an inguinal approach, the testis is delivered and removed along with the spermatic cord and its vascular and lymphatic pedicle, providing appropriate oncological control and allowing accurate histopathological diagnosis.
This is an important surgical principle: the first incision matters. An incorrect approach can complicate subsequent management, while the appropriate initial procedure can help ensure proper staging and treatment.
जब टेस्टिकुलर ट्यूमर (Testicular Tumour) का संदेह हो, तो सर्जरी का सही तरीका बहुत महत्वपूर्ण होता है। आमतौर पर अंडकोष (Scrotum) पर चीरा लगाने से बचना चाहिए, क्योंकि इससे अंडकोष की सामान्य लिम्फेटिक ड्रेनेज (Lymphatic drainage) प्रभावित हो सकती है और स्थानीय रूप से ट्यूमर कोशिकाओं के फैलने तथा बीमारी के फैलाव के तरीके में बदलाव का जोखिम बढ़ सकता है।
संदिग्ध टेस्टिकुलर कैंसर में मानक ऑन्कोलॉजिकल सर्जरी हाई इंग्वाइनल ऑर्किडेक्टॉमी (High Inguinal Orchidectomy) है। इसमें जांघ के ऊपरी हिस्से के पास इंग्वाइनल (Inguinal) रास्ते से अंडकोष को बाहर निकालकर, उसे स्पर्मेटिक कॉर्ड (Spermatic cord) तथा उसकी रक्त वाहिकाओं और लिम्फेटिक पेडिकल (Lymphatic pedicle) सहित हटाया जाता है। इससे उचित कैंसर सर्जरी सुनिश्चित होती है और सही हिस्टोपैथोलॉजिकल डायग्नोसिस (Histopathological diagnosis) में मदद मिलती है।
यह एक महत्वपूर्ण सर्जिकल सिद्धांत है: पहला चीरा बहुत मायने रखता है। गलत तरीके से किया गया पहला ऑपरेशन आगे के उपचार को जटिल बना सकता है, जबकि सही शुरुआती सर्जिकल प्रक्रिया बीमारी की उचित स्टेजिंग और आगे के उपचार में मदद करती है।
Advanced testicular cancer can still be curable, even when large residual lymph node masses remain after chemotherapy.
In this case, a 30-year-old man with a mixed germ cell tumor of the testis received systemic chemotherapy and subsequently underwent evaluation for a residual retroperitoneal lymph node mass. PET-CT showed significant residual masses measuring approximately 6 × 5 cm and 5 × 5 cm, located close to major blood vessels, including the aorta, inferior vena cava (IVC), and renal vessels.
Because of the size and location of the residual disease, surgery was technically challenging. The patient underwent exploratory laparotomy with retroperitoneal lymph node dissection (RPLND). Despite the close relationship of the tumor to the major vessels, a complete surgical resection was achieved safely, with removal of all visible residual tumor tissue.
In the video, He speaks in Gujarati, sharing his personal experience. He explains that he initially visited the clinic because he was experiencing significant pain. After a thorough medical evaluation, he was diagnosed with cancer and advised to undergo surgical intervention. Guided by the medical expertise of Dr. Swati Shah, He confidently went ahead with the recommended operation. The surgery was a success, and he reports receiving a highly positive response to the procedure. Following the operation, his comprehensive treatment plan also included a round of chemotherapy to reduce the risk of relapse.
This video presents a compelling testimonial from a testicular cancer survivor who received life-saving treatment from Dr. Swati Shah, an expert Uro and Gynecological Oncologist. In the brief clip, the patient recounts their challenging medical journey, focusing on the critical decision-making process regarding their surgical treatment plan. Initially confronted with the difficult prospect of traditional open surgery—which typically involves a longer, more painful healing process—the patient instead opted for a state-of-the-art robotic surgery performed by Dr. Shah. The survivor shares how this advanced, minimally invasive approach made a massive difference in their overall recovery.
The patient explains that he was initially diagnosed with testicular cancer five years ago. Unfortunately, eight months prior to the video, he faced a recurrence involving a retroperitoneal lymph node. After finding Dr. Swati Shah online, he underwent a complex robotic Retroperitoneal Lymph Node Dissection (RPLND) surgery performed by her. Speaking just two months post-operation, the patient highlights his remarkably smooth and rapid recovery, noting that his follow-up medical reports have all been positive. He expresses deep gratitude and recommends Dr. Shah.
A 32-year-old man had recurrence of NSGCT after orchidectomy and chemotherapy, with a significant residual retroperitoneal mass. Surgery was planned to address chemo-resistant teratoma and prevent local progression.
A 30-year-old man with metastatic germ cell tumour had a 4.5 cm calcified retroperitoneal mass and persistent pelvic lymphadenopathy after chemotherapy. The mass lay close to major vessels, so complete clearance by robotic RPLND was planned.
Details are anonymised and shown for education only.
Dr. Swati Shah operated successfully and provided excellent care throughout the treatment. She is highly skilled, compassionate, and undoubtedly the best doctor for testis cancer in Ahmedabad. We are very thankful for her guidance and expertise
I had an excellent experience with Dr. Swati Shah. She is one of the most skilled and compassionate doctors I have ever met. Her approach is very professional, and she explains every step of the treatment with great patience and clarity. The surgery was successful, and recovery was smooth under her guidance.
We had surgery done in Apollo Hospital. The doctor is very good and has done the options in a very good way. Now everything is fine.
Dr. Swati H. Shah is a uro- and gynaecologic oncosurgeon in Ahmedabad with experience in cancer surgery, robotic surgery and complex retroperitoneal tumour surgery. Her work includes testicular cancer surgery, RPLND and selected complex retroperitoneal masses. A second-opinion consultation focuses on reviewing the available evidence and clarifying whether surgery has a role within the overall treatment plan.
For a second opinion, bring your histopathology, tumour-marker reports, chemotherapy summary where applicable, and actual CT/MRI images. The consultation can help clarify your diagnosis, stage, surgical options and questions to discuss with your treating oncology team.
Shah’s Cancer & Robotic Surgery Centre, Gota, Ahmedabad | Apollo Hospital International, Ahmedabad
Appointment contact: +91 63590 11009
This page is for general education and does not replace an individual medical consultation. Do not delay urgent or time-critical treatment while seeking an online or in-person second opinion.
Swasth Parivar: every week, practical advice on recovery, diet and warning signs. No advertising. Stop any time.
Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.
